Markets › LSE › AZN.L

AstraZeneca PLC

LSE:AZN.LHealthcareFTSE:ASXFTSE:NMX

£124.84+0.68%Delayed 15 minIn session · ≈ AED 610.41 · Market cap $258.73B · Next earnings Fri 30 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	74.0%	60.9%	63.4%	73.9%	75.0%	81.9%	—	—
Operating margin	17.0%	7.6%	11.4%	20.5%	23.7%	23.4%	23.4%	+0.0 pts
Net margin	11.6%	0.3%	7.4%	13.0%	13.0%	17.4%	21.1%	+3.7 pts
EBITDA margin	27.5%	12.4%	19.5%	28.3%	28.1%	33.8%	—	—
Return on equity	21.7%	0.3%	8.9%	15.5%	16.9%	21.0%	25.5%	+4.4 pts
Return on assets	5.1%	0.1%	3.4%	6.0%	6.6%	9.0%	10.9%	+1.9 pts
Return on capital employed	10.7%	3.4%	7.2%	13.6%	16.4%	16.5%	—	—
Debt / equity	1.3×	0.8×	0.8×	0.7×	0.7×	0.6×	0.6×	−0.1%
Debt / assets	30.5%	29.1%	30.2%	28.1%	28.9%	26.0%	—	—
Interest coverage	6.4×	3.7×	5.7×	8.3×	9.2×	8.1×	—	—
Current ratio	1.0×	1.2×	0.9×	0.8×	0.9×	0.9×	0.9×	+0.0%
Quick ratio	0.8×	0.8×	0.7×	0.6×	0.7×	0.7×	—	—
Cash ratio	0.4×	0.3×	0.2×	0.2×	0.2×	0.2×	0.2×	+0.0%
Asset turnover	0.4×	0.4×	0.5×	0.5×	0.5×	0.5×	—	—
Inventory turnover	1.9×	1.6×	3.5×	2.3×	2.5×	1.6×	—	—
Receivables turnover	5.2×	4.2×	4.8×	3.9×	4.0×	3.6×	—	—
Dividend payout	105.4%	3,510.2%	133.0%	74.0%	67.2%	48.6%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.